BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3572803)

  • 1. Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs.
    Wills RJ; Gallo-Torres HE; Bertko R; Min BH
    J Pharmacol Exp Ther; 1987 May; 241(2):433-7. PubMed ID: 3572803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
    Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
    J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimoprostil plasma concentration--gastric acid inhibition relationships: potentiation by food.
    Wills RJ; Levine RA; Min BH; Schwartzel EH; Givens SV; Colburn WA; Gallo-Torres HE; Scheinbaum ML
    Clin Pharmacol Ther; 1985 Feb; 37(2):113-7. PubMed ID: 3967453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimoprostil plasma concentration-gastric acid inhibition relationships in duodenal ulcer patients.
    Wills RJ; O'Leary A; Givens SV; Scheinbaum ML
    J Clin Pharmacol; 1986 Jan; 26(1):48-54. PubMed ID: 3950051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-ulcerogenic and cytoprotective effects of trimoprostil (Ro 21-6937), a trimethylprostaglandin E2 derivative].
    Ohno T; Yamaguchi Y; Yajima T; Nakamura K
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):131-47. PubMed ID: 6607197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trimoprostil on gastric secretion in man.
    Ishimori A; Kawamura T; Koizumi F
    Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intragastric acidity under the prostaglandin E2 analog trimoprostil. Increased inhibitory effect through administration after meals].
    Dammann HG; Walter TA; Wolf N; Müller P; Simon B
    Arzneimittelforschung; 1986 Mar; 36(3):500-2. PubMed ID: 3518730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of a new prostaglandin E2 analogue (FCE 20700) on gastric acid and pepsin secretion in the dog.
    Soldani G; Mengozzi G; Arrigoni C; Ceserani R
    Prostaglandins Leukot Med; 1987 Jan; 26(1):11-20. PubMed ID: 3101072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals.
    Scarpignato C; Spina G; Signorini GC; Bertaccini G
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):211-28. PubMed ID: 6573736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute administration of a prostaglandin E2 analog, trimoprostil, on esophageal motility in man.
    Schwartz GJ; Levine RA; Petokas S; Gallo-Torres HE; Scheinbaum ML; Sondheimer JM
    Am J Gastroenterol; 1987 Sep; 82(9):836-9. PubMed ID: 3631029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimoprostil, a prostaglandin E2 analogue, on human gastric acid secretion and soluble mucin output.
    Lee SP; Nicholls JF; Robertson AM
    Eur J Clin Invest; 1987 Feb; 17(1):1-6. PubMed ID: 2436919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trimoprostil on healing and recurrence of acetic acid-induced gastric ulcer in rats.
    Umeda Y; Nakamura K
    Jpn J Pharmacol; 1986 Dec; 42(4):457-63. PubMed ID: 3807049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal and cardiovascular effects of the prostaglandin analogue Hoe 260.
    Bickel M; Bartmann W; Beck G; Lerch U; Schleyerbach R; Schölkens BA
    Biomed Biochim Acta; 1984; 43(8-9):S235-8. PubMed ID: 6596097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
    Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nocturnal gastric secretion by trimoprostil, a synthetic prostanoid.
    Penston J; Johnston DA; Wilson JA; Wormsley KG
    Curr Med Res Opin; 1986; 10(3):145-9. PubMed ID: 3089691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundic inhibition of acid secretion and gastrin release in the dog.
    Soon-Shiong P; Debas HT
    Gastroenterology; 1980 Nov; 79(5 Pt 1):867-72. PubMed ID: 7419010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.